An update on etiology, prevention, and therapy of postthrombotic syndrome

Journal of Vascular Surgery

Volumn 53, Issue 2, 2011, Pages 500-509

  Henke, Peter K ^a   Comerota, Anthony J ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b TOLEDO HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ANTICOAGULATION; ARTICLE; BLOOD CLOT LYSIS; COMPRESSION GARMENT; DEEP VEIN THROMBOSIS; HUMAN; PATHOPHYSIOLOGY; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; THROMBECTOMY; THROMBUS;

EID: 79251600301     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.08.050     Document Type: Review

References (85)

1. S.R. Kahn The post-thrombotic syndrome: progress and pitfalls Br J Haematol 134 2006 357 365
2. J.J. Smith, M.G. Guest, R.M. Greenhalgh, and A.H. Davies Measuring the quality of life in patients with venous ulcers J Vasc Surg 31 2000 642 649
3. C.V. Ruckley Socioeconomic impact of chronic venous insufficiency and leg ulcers Angiology 48 1997 67 69
4. C.J. van Dongen, P. Prandoni, M. Frulla, A. Marchiori, M.H. Prins, and B.A. Hutten Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome J Thromb Haemost 3 2005 939 942
5. P. Prandoni, A.W. Lensing, A. Cogo, S. Cuppini, S. Villalta, and M. Carta The long-term clinical course of acute deep venous thrombosis Ann Intern Med 125 1996 1 7
6. S.R. Kahn, I. Shrier, J.A. Julian, T. Ducruet, L. Arsenault, and M.J. Miron Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis Ann Intern Med 149 2008 698 707
7. S.R. Kahn, H. Partsch, S. Vedantham, P. Prandoni, and C. Kearon Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization J Thromb Haemost 7 2009 879 883
8. B. Eklof, R.B. Rutherford, J.J. Bergan, P.H. Carpentier, P. Gloviczki, and R.L. Kistner Revision of the CEAP classification for chronic venous disorders: consensus statement J Vasc Surg 40 2004 1248 1252
9. T. Vrtiska, and J. Glockner Computed tomography and magnetic resonance imaging in venous disease P. Gloviczki, Handbook of venous disorders 3rd ed. 2009 Edward Arnold London 169 192
10. P. Henke Venous pathology J. Cronenwett, K.W. Johnston, 7th ed. Rutherford's vascular surgery Vol 1 2010 Saunders Elsevier Philadelphia 163 176
11. J.J. Bergan, G.W. Schmid-Schonbein, P.D. Smith, A.N. Nicolaides, M.R. Boisseau, and B. Eklof Chronic venous disease N Engl J Med 355 2006 488 498
12. P. Zamboni, S. Tognazzo, M. Izzo, F. Pancaldi, G.L. Scapoli, and A. Liboni Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration J Vasc Surg 42 2005 309 314
13. J.H. Haenen, M.C. Janssen, H. Wollersheim, M.A. Van't Hof, M.J. de Rooij, and H. van Langen The development of postthrombotic syndrome in relationship to venous reflux and calf muscle pump dysfunction at 2 years after the onset of deep venous thrombosis J Vasc Surg 35 2002 1184 1189
14. T.W. Wakefield, D.D. Myers, and P.K. Henke Mechanisms of venous thrombosis and resolution Arterioscler Thromb Vasc Biol 28 2008 387 391
15. P.K. Henke, and T. Wakefield Thrombus resolution and vein wall injury: dependence on chemokines and leukocytes Thromb Res 123 suppl 4 2009 S72 S78
16. P.K. Henke, M.R. Varma, D.K. Moaveni, N.A. Dewyer, A.J. Moore, and E.M. Lynch Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis Thromb Haemost 98 2007 1045 1055
17. E.G. Brooks, W. Trotman, M.P. Wadsworth, D.J. Taatjes, M.F. Evans, and F.P. Ittleman Valves of the deep venous system: an overlooked risk factor Blood 114 2009 1276 1279
18. P.K. Henke, A. Varga, S. De, C.B. Deatrick, J. Eliason, and D.A. Arenberg Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model Arterioscler Thromb Vasc Biol 24 2004 1130 1137
19. K.B. Deatrick, J.L. Eliason, E.M. Lynch, A.J. Moore, N.A. Dewyer, and M.R. Varma Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model J Vasc Surg 42 2005 140 148
20. V. Sood, C. Luke, E. Miller, M. Mitsuya, G.R. Upchurch Jr, and T.W. Wakefield Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline Ann Vasc Surg 24 2010 233 241
21. P.K. Henke, M.R. Varma, K.B. Deatrick, N.A. Dewyer, E.M. Lynch, and A.J. Moore Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization Thromb Haemost 95 2006 272 281
22. D.D. Myers Jr, P.K. Henke, P.W. Bedard, S.K. Wrobleski, N. Kaila, and G. Shaw Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis J Vasc Surg 44 2006 625 632
23. T. Zhu, I. Martinez, and J. Emmerich Venous thromboembolism: risk factors for recurrence Arterioscler Thromb Vasc Biol 29 2009 298 310
24. B. Furie, and B.C. Furie Mechanisms of thrombus formation N Engl J Med 359 2008 938 949
25. D.K. Moaveni, E.M. Lynch, C. Luke, V. Sood, G.R. Upchurch, and T.W. Wakefield Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin J Vasc Surg 47 2008 616 624
26. W.C. Aird Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms Circ Res 100 2007 158 173
27. W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, and M.R. Lassen Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 suppl 2008 381 453S
28. A.K. Kakkar, A.T. Cohen, V.F. Tapson, J.F. Bergmann, S.Z. Goldhaber, and B. Deslandes Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients Ann Surg 251 2010 330 338
29. V. Bahl, H.M. Hu, P.K. Henke, T.W. Wakefield, D.A. Campbell Jr, and J.A. Caprini A validation study of a retrospective venous thromboembolism risk scoring method Ann Surg 251 2009 344 350
30. W. Geerts Antithrombotic and thrombolytic therapy Chest 133 8th Ed: ACCP Guidelines 2008 381 451s
31. J.C. Farkas, C. Chapuis, S. Combe, M. Silsiguen, J. Marzelle, and C. Laurian A randomised controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing vascular surgery Eur J Vasc Surg 7 1993 554 560
32. E. de Maistre, B. Terriat, A.S. Lesne-Padieu, N. Abello, O. Bouchot, and E.F. Steinmetz High incidence of venous thrombosis after surgery for abdominal aortic aneurysm J Vasc Surg 49 2009 596 601
33. R.D. Hull, G.E. Raskob, D. Rosenbloom, A.A. Panju, P. Brill-Edwards, and J.S. Ginsberg Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis N Engl J Med 322 1990 1260 1264
34. G. Bratt, E. Tornebohm, L. Widlund, and D. Lockner Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers Thromb Res 42 1986 613 620
35. L. Bara, E. Billaud, G. Gramond, A. Kher, and M. Samama Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration Thromb Res 39 1985 631 636
36. A.W. Lensing, M.H. Prins, B.L. Davidson, and J. Hirsh Treatment of deep venous thrombosis with low-molecular-weight heparins A meta-analysis Arch Intern Med 155 1995 601 607
37. R.D. Hull, G.F. Pineo, R. Brant, J. Liang, R. Cook, and S. Solymoss Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome Am J Med 122 2009 762 769 e763
38. J.A. Gonzalez-Fajardo, M. Martin-Pedrosa, J. Castrodeza, S. Tamames, and C. Vaquero-Puerta Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: comparative study of enoxaparin versus coumarin J Vasc Surg 48 2008 953 959
39. T.E. Warkentin Heparin-induced thrombocytopenia: a clinicopathologic syndrome Thromb Haemost 82 1999 439 447
40. N. Martel, J. Lee, and P.S. Wells Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis Blood 106 2005 2710 2715
41. M.N. Levine, J. Hirsh, M. Gent, A.G. Turpie, J. Weitz, and J. Ginsberg Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis Thromb Haemost 74 1995 606 611
42. S. Schulman, A.S. Rhedin, P. Lindmarker, A. Carlsson, G. Lrfars, and P. Nicol A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism Duration of Anticoagulation Trial Study Group N Engl J Med 332 1995 1661 1665
43. C. Kearon, M. Gent, J. Hirsh, J. Weitz, M.J. Kovacs, and D.R. Anderson A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism N Engl J Med 340 1999 901 907
44. P.M. Ridker, S.Z. Goldhaber, E. Danielson, Y. Rosenberg, C.S. Eby, and S.R. Deitcher Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism N Engl J Med 348 2003 1425 1434
45. P.S. Wells, D.R. Anderson, M. Rodger, M. Forgie, C. Kearon, and J. Dreyer Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis N Engl J Med 349 2003 1227 1235
46. P. Prandoni, A.W. Lensing, M.H. Prins, E. Bernardi, A. Marchiori, and P. Bagatella Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism Ann Intern Med 137 2002 955 960
47. S. Eichinger, E. Minar, C. Bialonczyk, M. Hirschl, P. Quehenberger, and B. Schneider D-dimer levels and risk of recurrent venous thromboembolism JAMA 290 2003 1071 1074
48. G. Palareti, B. Cosmi, C. Legnani, A. Tosetto, C. Brusi, and A. Iorio D-dimer testing to determine the duration of anticoagulation therapy N Engl J Med 355 2006 1780 1789
49. P. Simioni, D. Tormene, L. Spiezia, G. Tognin, V. Rossetto, and C. Radu Inherited thrombophilia and venous thromboembolism Semin Thromb Hemost 32 2006 700 708
50. J.B. Segal, D.J. Brotman, A.J. Necochea, A. Emadi, L. Samal, and L.M. Wilson Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review JAMA 301 2009 2472 2485
51. W. Blattler, and H. Partsch Leg compression and ambulation is better than bed rest for the treatment of acute deep venous thrombosis Int Angiol 22 2003 393 400
52. H. Partsch, and W. Blattler Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin J Vasc Surg 32 2000 861 869
53. P.K. Henke, E. Ferguson, M. Varma, K.B. Deatrick, G.T. Wakefield, and D.T. Woodrum Proximate versus nonproximate risk factor associated primary deep venous thrombosis: clinical spectrum and outcomes J Vasc Surg 45 2007 998 1003 discussion 1003-4; quiz 1005-7
54. P. Prandoni, A.W. Lensing, M.H. Prins, M. Frulla, A. Marchiori, and E. Bernardi Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial Ann Intern Med 141 2004 249 256
55. D.P. Brandjes, H.R. Buller, H. Heijboer, M.V. Huisman, M. de Rijk, and H. Jagt Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis Lancet 349 1997 759 762
56. M. Aschwanden, C. Jeanneret, M.T. Koller, C. Thalhammer, H.C. Bucher, and K.A. Jaeger Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial J Vasc Surg 47 2008 1015 1021
57. S.R. Kahn, H. Shbaklo, S. Shapiro, P.S. Wells, M.J. Kovacs, and M.A. Rodger Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial BMC Cardiovasc Disord 7 2007 21
58. H. Akesson, L. Brudin, J.A. Dahlstrom, B. Eklof, P. Ohlin, and G. Plate Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation Eur J Vasc Surg 4 1990 43 48
59. K.T. Delis, D. Bountouroglou, and A.O. Mansfield Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life Ann Surg 239 2004 118 126
60. Grewal N, Martinez J, Andrews L, Comerota AJ. Successful thrombolysis of iliofemoral deep venous thrombosis reduces potthrombotic morbidity. Presented at: Thirty-second Annual Meeting of the Midwestern Vascular Surgical Society, Sept 10-12, 2009, Madison, WI.
61. C. Kearon, S.R. Kahn, G. Agnelli, S. Goldhaber, G.E. Raskob, and A.J. Comerota Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 6 suppl 2008 454 545S
62. G. Plate, E. Einarsson, P. Ohlin, R. Jensen, P. Qvarfordt, and B. Eklof Thrombectomy with temporary arteriovenous fistula: the treatment of choice in acute iliofemoral venous thrombosis J Vasc Surg 1 1984 867 876
63. G. Plate, H. Akesson, E. Einarsson, P. Ohlin, and B. Eklof Long-term results of venous thrombectomy combined with a temporary arterio-venous fistula Eur J Vasc Surg 4 1990 483 489
64. G. Plate, B. Eklof, L. Norgren, P. Ohlin, and J.A. Dahlstrom Venous thrombectomy for iliofemoral vein thrombosis10-year results of a prospective randomised study Eur J Vasc Endovasc Surg 14 1997 367 374
65. A.J. Comerota, and S.S. Gale Technique of contemporary iliofemoral and infrainguinal venous thrombectomy J Vasc Surg 43 2006 185 191
66. Patterson BO, Hinchliffe R, Loftus IM, Thompson MM, Holt PJ. Indications for catheter-directed thrombolysis in the management of acute proximal deep venous thrombosis. Arterioscler Thromb Vasc Biol 30:669-74.
67. H. Bjarnason, J.R. Kruse, D.A. Asinger, G.K. Nazarian, C.A. Dietz Jr, and M.D. Caldwell Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy J Vasc Interv Radiol 8 1997 405 418
68. M.W. Mewissen, G.R. Seabrook, M.H. Meissner, J. Cynamon, N. Labropoulos, and S.H. Haughton Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry Radiology 211 1999 39 49
69. A.J. Comerota Catheter-directed thrombolysis for the treatment of acute iliofemoral deep venous thrombosis Phlebology 15 2001 149 155
70. J. Martinez, A.J. Comerota, Z. Assi, R.S. DiSalle, and D.M. Sepanski Isolated segmental pharmacomechanical thrombolysis for the treatment of iliofemoral venous thrombosis Phlebology 22 2007 223 242
71. A.J. Comerota, R.C. Throm, S.D. Mathias, S. Haughton, and M. Mewissen Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life J Vasc Surg 32 2000 130 137
72. M. Elsharawy, and E. Elzayat Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis A randomised clinical trial Eur J Vasc Endovasc Surg 24 2002 209 214
73. T. Enden, L. Sandvik, N.E. Klow, C.E. Slagsvold, W. Ghanima, and G. Hafsahl Catheter-directed venous thrombolysis in acute iliofemoral vein thrombosis-the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771) Am Heart J 154 2007 808 814
74. K.T. Delis, H. Bjarnason, P.W. Wennberg, T.W. Rooke, and P. Gloviczki Successful iliac vein and inferior vena cava stenting ameliorates venous claudication and improves venous outflow, calf muscle pump function, and clinical status in post-thrombotic syndrome Ann Surg 245 2007 130 139
75. P. Neglen, K.C. Hollis, J. Olivier, and S. Raju Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result J Vasc Surg 46 2007 979 990
76. S. Raju, R. Darcey, and P. Neglen Unexpected major role for venous stenting in deep reflux disease J Vasc Surg 51 2010 401 408 discussion 408
77. B.S. Knipp, E. Ferguson, D.M. Williams, N.J. Dasika, W. Cwikiel, and P.K. Henke Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome J Vasc Surg 46 2007 743 749
78. S. Raju, R.K. Fredericks, P.N. Neglen, and J.D. Bass Durability of venous valve reconstruction techniques for "primary" and postthrombotic reflux J Vasc Surg 23 1996 357 366 discussion 366-7
79. S. Raju, P. Neglen, J. Doolittle, and E.F. Meydrech Axillary vein transfer in trabeculated postthrombotic veins J Vasc Surg 29 1999 1050 1062 discussion 1062-4
80. J.D. Bry, P.A. Muto, T.F. O'Donnell, and L.A. Isaacson The clinical and hemodynamic results after axillary-to-popliteal vein valve transplantation J Vasc Surg 21 1995 110 119
81. A.A. Ramelet, M.R. Boisseau, C. Allegra, A. Nicolaides, K. Jaeger, and P. Carpentier Veno-active drugs in the management of chronic venous disease An international consensus statement: current medical position, prospective views and final resolution Clin Hemorheol Microcirc 33 2005 309 319
82. D. Pavcnik, J. Kaufman, B. Uchida, L. Correa, T. Hiraki, and S.C. Kyu Second-generation percutaneous bioprosthetic valve: a short-term study in sheep J Vasc Surg 40 2004 1223 1227
83. E.M. Roumen-Klappe, M.C. Janssen, J. van Rossum, S. Holewijn, M.M. Van Bokhoven, and K. Kaasjager Inflammation in deep-vein thrombosis and the development of the post-thrombotic syndrome: a prospective study J Thromb Haemost 7 2009 582 587
84. R.J. Glynn, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr, and J.J. Kastelein A randomized trial of rosuvastatin in the prevention of venous thromboembolism N Engl J Med 360 2009 1851 1861
85. J.J. Li, Y.S. Li, J. Chen, and J.Q. Yang Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy Med Hypotheses 66 2006 1199 1204